Covered recipient · General Payments record
KEROLOS GEORGE RIZK
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$2,550.08
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $998.23 | 43 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $100.00 | 1 |
| PFIZER INC. | $83.92 | 4 |
| EISAI INC. | $75.70 | 4 |
| Merck Sharp & Dohme Corporation | $72.11 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $68.10 | 3 |
| Celgene Corporation | $61.78 | 3 |
| E.R. Squibb & Sons, L.L.C. | $53.78 | 3 |
| Lilly USA, LLC | $49.55 | 2 |
| Daiichi Sankyo Inc. | $47.57 | 2 |
| GENZYME CORPORATION | $38.78 | 1 |
| Gilead Sciences, Inc. | $26.93 | 1 |
| TAIHO ONCOLOGY, INC. | $26.73 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.45 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.92 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.52 | 1 |
| Alnylam Pharmaceuticals Inc. | $23.52 | 1 |
| ARRAY BIOPHARMA INC | $21.93 | 1 |
| Exelixis Inc. | $21.66 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.53 | 1 |
| EMD Serono, Inc. | $19.18 | 1 |
| ABBVIE INC. | $17.12 | 1 |
| GlaxoSmithKline, LLC. | $16.85 | 1 |
| Genentech USA, Inc. | $16.71 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $16.71 | 1 |
| BeiGene USA, Inc. | $16.52 | 1 |
| Pharmacosmos Therapeutics Inc. | $14.96 | 1 |
| Astellas Pharma US Inc | $14.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (43)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.